Single cell RNA sequencing analyses indicate that CLRs are highly expressed in the innate immune cells of patients with severe COVID-19 [87, 94], and a proteomic profiling study indicates that DC-SIGN is a mediator of genetic risk in COVID-19 [95]. This evidence concerns the gene CD209 and COVID-19.